Status:
RECRUITING
Austrian Registry on Transjugular Intrahepatic Portosystemic Shunts
Lead Sponsor:
Thomas Reiberger
Collaborating Sponsors:
Austrian Association of Gastroenterology and Hepatology
Conditions:
Portal Hypertension
Eligibility:
All Genders
18-99 years
Brief Summary
Patients with TIPS will be recruited in this prospective registry study. The clinical course will be documented and biomarkers for prediction of complicatiosn will be assessed.
Detailed Description
Patients with advanced chronic liver disease may develop portal hypertension, which is the main cause for most complications and deaths of patients with liver cirrhosis. Implantation of a transjugular...
Eligibility Criteria
Inclusion
- Age 18-99 years
- Portal hypertension
- Anticipated or past implantation of a transjugular intrahepatic portosystemic shunt (TIPS)
- Informed consent
Exclusion
- Retraction of consent
Key Trial Info
Start Date :
March 28 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT03409263
Start Date
March 28 2018
End Date
December 31 2027
Last Update
November 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna
Vienna, Vienna, Austria, 1090